Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

0.83

Margin Of Safety %

6

Put/Call OI Ratio

0.92

EPS Next Q Diff

-0.1

EPS Last/This Y

1.4

EPS This/Next Y

0.48

Price

113.46

Target Price

132.05

Analyst Recom

1.77

Performance Q

-3.68

Relative Volume

1.27

Beta

0.73

Ticker: ABT




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19ABT112.430.920.66223585
2024-12-20ABT114.220.921.78231733
2024-12-23ABT114.310.840.76199440
2024-12-24ABT114.760.861.00205643
2024-12-26ABT115.260.860.59206444
2024-12-27ABT1150.861.02208282
2024-12-30ABT112.780.861.15201746
2024-12-31ABT113.10.860.43202802
2025-01-02ABT113.470.860.83203701
2025-01-03ABT113.820.870.47205437
2025-01-06ABT113.060.852.98201876
2025-01-07ABT113.40.930.59212588
2025-01-08ABT114.250.930.73216578
2025-01-09ABT114.250.930.72216578
2025-01-10ABT112.310.930.56218485
2025-01-13ABT113.170.921.23216347
2025-01-14ABT1130.910.04217914
2025-01-15ABT111.10.940.65219070
2025-01-16ABT113.910.930.80220034
2025-01-17ABT113.490.920.99222872
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19ABT112.4212.82051.54.68
2024-12-20ABT114.2212.82164.44.68
2024-12-23ABT114.3112.82025.94.68
2024-12-24ABT114.7612.82055.24.68
2024-12-26ABT115.2712.82059.84.68
2024-12-27ABT115.0312.82000.74.68
2024-12-30ABT112.7812.81845.64.68
2024-12-31ABT113.1312.82046.04.68
2025-01-02ABT113.4712.82048.44.68
2025-01-03ABT113.8212.82049.94.68
2025-01-06ABT113.0412.81956.84.68
2025-01-07ABT113.4212.82050.04.68
2025-01-08ABT114.2512.82114.54.68
2025-01-09ABT114.2512.82046.54.68
2025-01-10ABT112.2912.81890.84.68
2025-01-13ABT113.1812.82116.74.68
2025-01-14ABT113.0112.82032.14.68
2025-01-15ABT111.0912.81845.04.68
2025-01-16ABT113.9012.82275.04.68
2025-01-17ABT113.4612.82010.24.68
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19ABT-2.55-1.000.79
2024-12-20ABT-2.55-1.000.79
2024-12-23ABT-2.51-1.000.79
2024-12-24ABT-2.51-1.000.79
2024-12-26ABT-2.54-1.000.70
2024-12-27ABT-2.55-1.000.70
2024-12-30ABT-2.55-1.110.70
2024-12-31ABT-2.55-1.110.70
2025-01-02ABT-2.54-1.110.70
2025-01-03ABT-2.55-1.110.70
2025-01-06ABT-2.54-1.110.70
2025-01-07ABT-2.54-1.110.70
2025-01-08ABT-2.55-1.110.70
2025-01-09ABT-2.55-1.110.70
2025-01-10ABT-2.55-1.110.70
2025-01-13ABT-2.55-1.000.83
2025-01-14ABT-2.55-1.000.83
2025-01-15ABT-2.55-1.000.83
2025-01-16ABT-2.55-1.000.83
2025-01-17ABT-2.55-1.000.83
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

1.21

Avg. EPS Est. Current Quarter

1.34

Avg. EPS Est. Next Quarter

1.11

Insider Transactions

-2.55

Institutional Transactions

-1

Beta

0.73

Average Sales Estimate Current Quarter

11031

Average Sales Estimate Next Quarter

10652

Fair Value

120.17

Quality Score

93

Growth Score

82

Sentiment Score

95

Actual DrawDown %

20.4

Max Drawdown 5-Year %

-33.9

Target Price

132.05

P/E

34.51

Forward P/E

22.01

PEG

4.23

P/S

4.78

P/B

4.95

P/Free Cash Flow

30.35

EPS

3.29

Average EPS Est. Cur. Y​

4.68

EPS Next Y. (Est.)

5.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.94

Relative Volume

1.27

Return on Equity vs Sector %

-4.6

Return on Equity vs Industry %

1.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

2010.2
Abbott Laboratories
Sector: Healthcare
Industry: Medical Devices
Employees: 114000
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
stock quote shares ABT – Abbott Laboratories Stock Price stock today
news today ABT – Abbott Laboratories stock forecast ,stock prediction 2023 2024 2025
marketwatch ABT – Abbott Laboratories yahoo finance google finance
stock history ABT – Abbott Laboratories invest stock market
stock prices ABT premarket after hours
ticker ABT fair value insiders trading